Edition:
United States

BLIS Technologies Ltd (BLT.NZ)

BLT.NZ on New Zealand Stock Exchange

0.04NZD
7 Dec 2016
Change (% chg)

-- (--)
Prev Close
$0.04
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
417,183
52-wk High
$0.06
52-wk Low
$0.03

Summary

Name Age Since Current Position

Peter Fennessy

Non-Executive Independent Chairman of the Board

Brian Watson

2016 Chief Executive Officer

A. Offen

2014 Executive Deputy Chairman of the Board

Alan McKenzie

2012 Independent Director

Veronica Aris

2014 Non-Executive Independent Director

Graeme Boyd

2014 Non-Executive Independent Director

Bevan Wallace

Non-Executive Independent Director

Biographies

Name Description

Peter Fennessy

Dr. Peter Francis Fennessy serves as Non-Executive Independent Chairman of the Board of the Company. Peter Fennessy is a consultant, and a Director of AbacusBio Limited (Dunedin), a privately-held consultancy and venture development business with its major focus in the agricultural sector. Peter has been a director of BLIS Technologies Ltd since 2000 and Chairman since 2006; he is also a director of a number of private companies in the areas of technology and agribusiness.

Brian Watson

Mr. Brian Watson has been appointed as Chief Executive Officer of the Company., effective February 2016. Mr. Watson is currently Group Manager Preparedness & Response at Fonterra. He has been with Fonterra since 2011 and prior to that held a number of management and marketing positions in the pharmaceutical industry.

A. Offen

Mr. A.P. (Tony) Offen has been appointed as Executive Deputy Chairman of the Board of BLIS Technologies Ltd., with effect from 1 September 2014. Mr Offen has been a director of BLIS Technologies Limited since May 2009, is the current Deputy Chair and Chair of the Audit Committee. Through his Dunedin based investment company, Edinburgh Securities Limited, is a director and shareholder of private companies successfully operating in a number of business areas including commercial and industrial property, FMCG business sectors nationally and internationally as well as investment interests requiring venture and start-up capital. Mr Offen holds professional memberships with the NZ Institute of Chartered Accountants and the NZ Institute of Directors, is an elected member of the National Council for the Neurological Foundation of NZ and is Chairman of its investment committee. Mr Offen is also a member of the Governance Board of Brain Research New Zealand, Centre of Research Excellence (CoRE) and holds a B.Com (Accounting) and B.A. (Philosophy) from University of Otago.

Alan McKenzie

Mr. Alan J. McKenzie is Alan is an Independent Director of the Company. Alan is a Dunedin based business adviser with over 35 years experience as a Chartered Accountant working in New Zealand and overseas, in both Public Practice and Industry. He has worked with numerous businesses ranging from new ventures requiring day to day input, to substantial multi-national companies. His focus is advising clients regarding structuring business investment, financing, and related taxation issues. He is a Fellow Chartered Director and a director of several client owned businesses and investment groups, operating within New Zealand and Internationally. He is a Trustee for several private family groups and local Charitable Organisations.

Veronica Aris

Ms. Veronica Aris serves as an Non-Executive Independent Director of BLIS Technologies Ltd. Veronica Aris has over 17 years of Sales and Marketing experience with the Healthcare Industry having held numerous senior roles across many industry sectors including Primary Care Consumables, Pharmaceutical, Natural Health Care Supplements and Consumer Products for companies such as Sanofi-Synthelabo, Pfizer, Abbott Laboratories, EBOS and Brand Developers within the UK, AU and NZ markets. She has expertise in the areas of Pharma Product launches, brand management, marketing, sales, regulatory affairs as well as social media sales strategies. Originally from the UK, Veronica holds a BSc in Chemistry and French and a DipM in Marketing. She is a Board Member of North Harbour Softball, a Member of the Institute of Directors and holds Chartered Marketer status from the Chartered Institute of Marketers.

Graeme Boyd

Mr. Graeme S. Boyd serves as an Non-Executive Independent Director of the BLIS Technologies Ltd. Graeme joined ICI New Zealand Limited in 1971 and over 26 years held a variety of positions across the business including management of the Pharmaceuticals Division, culminating in the role of NZ General Manager from 1990 to 1997. He was appointed CEO of Comvita in 1998 and developed the company from a small privately owned company to a publicly listed company centred on marketing natural health products internationally. Graeme left Comvita in 2005 and formed a management consulting business specialising in company turnarounds, growth strategies and international marketing. He is currently an independent director of Allied Industrial Engineering Limited, Blokart International Limited and Chairman of Phytomed Medicinal Herbs Limited. Graeme has also been a member of the Institute of Directors since 2004 and is a fully accredited professional director.

Bevan Wallace

Mr. Bevan Q. H. Wallace serves as Non-Executive Independent Director of BLIS Technologies Ltd. Bevan Wallace joined the Board of Directors at BLIS Technologies in 2008. He is a former Chartered Accountant, a Fellow Institute of Financial Professionals, New Zealand (Inc), and a member of the Institute of Directors and the Law and Economics Association of New Zealand (Inc.). Bevan is Chairman of Efficient Market Services Limited, operator of the Unlisted share trading platform and provides value-based strategic advice though his consultancy Morgan Wallace Limited. He holds a Master of Commerce with First Class Honours in Economics and Accountancy (University of Canterbury).

Basic Compensation

Name Fiscal Year Total

Peter Fennessy

40,000

Brian Watson

--

A. Offen

28,750

Alan McKenzie

20,000

Veronica Aris

13,333

Graeme Boyd

13,333

Bevan Wallace

22,917
As Of  30 Mar 2015

Options Compensation